Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 7/20 | 0.39 |
| ▸ | GNPAT | O15228 | 1/20 | 0.39 |
| ▸ | BMP1 | P13497 | 2/20 | 0.37 |
| ▸ | CTSD | P07339 | 4/20 | 0.36 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1499722 | 1.00 | TASP1 (0.43) | TASP1BACE1GNPATBMP1CTSD | |
| SCHEMBL23133286 | 1.00 | TASP1 (0.43) | TASP1BACE1GNPATBMP1CTSD | |
| SCHEMBL29946126 | 0.88 | TASP1 (0.45) | TASP1BACE1GNPATBMP1CTSD | |
| SCHEMBL20257262 | 0.87 | FNTA (0.42) | TASP1BMP1CASP1 | |
| SCHEMBL29664764 | 0.84 | TASP1 (0.56) | TASP1BACE1GNPATBMP1BACE2 | |
| SCHEMBL12149975 | 0.83 | BACE1 (0.47) | BACE1GNPATBMP1CTSDBACE2 | |
| SCHEMBL24616790 | 0.83 | TASP1 (0.48) | TASP1GNPATBMP1PTPN1SIRT5 | |
| SCHEMBL29946268 | 0.80 | TASP1 (0.51) | TASP1BACE1GNPATBMP1BACE2 | |
| SCHEMBL31107824 | 0.79 | GNPAT (0.51) | BACE1GNPATBACE2 | |
| SCHEMBL30464991 | 0.79 | GNPAT (0.51) | BACE1GNPATBACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210088504-A1 | PROTEIN DEGRADATION INDUCING TAG AND USAGE THEREOF | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2021-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210088504-A1 | PROTEIN DEGRADATION INDUCING TAG AND USAGE THEREOF | SENP8, SENP6, SENP7 | TASP1 1024/4885BACE1 1145/4885GNPAT 2297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.